达沙替尼布诱导的胆胸病治疗5年以后:实际上有没有任何限制?
Alberto Garcia-Zamalloa1,2, Begoña Basauri3, Goretti Urcelay3
1Internal Medicine Service, Mendaro Hospital, Osakidetza/Basque Health Service, Gipuzkoa, Spain.
European journal of case reports in internal medicine
|July 17, 2023
概括
达沙替尼,白血病的治疗,可以导致胆胸部,一种罕见的多发性溢出. 这项研究报告了一例超过5年的治疗病例,强调需要对这种氨酸激酶抑制剂保持持续警.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
背景情况:
- 达沙替尼 (Dasatinib) 是一种针对特定白血病的氨酸激酶抑制剂.
- 胸腔溢液是达沙替尼的已知不良影响之一.
- 胆胸是一种非常罕见但严重的不良影响.
研究的目的:
- 报告第一个达沙提尼布诱导的胸病例,超过5年的治疗.
- 为了调查与达沙替尼布相关的胆胸的发生.
- 突出考虑戒药管理的重要性.
主要方法:
- 一位长期接受达沙替尼治疗的患者的病例报告.
- 关于与达沙替尼布相关的胆胸病例报告的文献综述.
- 药物停用后治疗结果的分析.
主要成果:
- 一名接受达沙替尼布治疗超过10年的患者患上了胆胸.
- 药物戒断成功地解决了肌性肺.
- 另外还发现了14例与达沙替尼布相关的胆胸病例.
结论:
- 在达沙替尼治疗期间,即使超过5年,也可能发生胆胸病.
- 达沙替尼布诱导的胆胸的潜在机制尚不清楚.
- 药物戒断是达沙替尼与达沙替尼相关的胆胸病的有效管理策略.
更多相关视频
相关概念视频
Pneumothorax-II
206
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
206
Chronic Kidney Disease II: Clinical Manifestations
35
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
35
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Endoscopic Studies II: Thoracocentesis
348
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
348
Chronic Kidney Disease IV: Nursing Management
26
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
26


